- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
-
- HANO Kotobuki
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Osaka University
-
- AKASHI Akira
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Osaka University
-
- YAMAMOTO Itaru
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Osaka University
-
- NARUMI Shigehiko
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, Osaka University
-
- HORII Zen-ichi
- Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Osaka University
-
- NINOMIYA Ichiya
- Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Osaka University
Search this article
Description
A series of 4-alkyltriazeno-imidazole (or -triazole)-5-carboxamides were tested for their growth-inhibitory effect on Ehrlich tumor. Of the compounds tested, 4-dimethyltri-azenoimidazole-5-carboxamide and 4-dipropyltriazeno-imidazole (or -traizole)-5-carboxamide were found to be the most effective inhibitor of solid tumor. Except for 4-diazoimidazole-5-carboxamide, none of the compounds tested had any effect on the ascites form.
Journal
-
- GANN Japanese Journal of Cancer Research
-
GANN Japanese Journal of Cancer Research 56 (4), 417-420, 1965
The Japanese Cancer Association